The European VAPA project is working to develop a virtual treatment option for patients with pulmonary or cardiovascular diseases. The first clinical trials generated positive results, but from next month all financing will have been exhausted. The project leader is willing to use his own savings and aims to collaborate with hospitals.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.